Created at	Source	Raw Value	Validated value
Oct. 26, 2020, 11:31 p.m.	usa	Change from baseline serum Tumor necrosis factor-α concentration at end of the trial;Change from baseline serum Interleukin-6 concentration at end of the trial;Change from baseline serum monocyte chemoattractant protein 1 (MCP-1) at end of the trial;Change from baseline Serum ferritin level at end of the trial;Change from baseline score of Nutrition risk screening-2002 (NRS-2002) at end of the trial;Change from baseline serum C-reactive protein concentration at end of the trial	Change from baseline serum Tumor necrosis factor-α concentration at end of the trial;Change from baseline serum Interleukin-6 concentration at end of the trial;Change from baseline serum monocyte chemoattractant protein 1 (MCP-1) at end of the trial;Change from baseline Serum ferritin level at end of the trial;Change from baseline score of Nutrition risk screening-2002 (NRS-2002) at end of the trial;Change from baseline serum C-reactive protein concentration at end of the trial